People · Operator
Named in public records as an officer, director or promoter · active 2011–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $107.5M | $3.0B | 2011 |
ROGER G MILLS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROGER G MILLS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ULI HACKSELL | 1 | 3 |
| LAURA A BREGE | 1 | 1 |
| WILLIAM M WELLS | 1 | 1 |
| THOMAS H AASEN | 1 | 1 |
| LESTER J KAPLAN | 1 | 1 |
| LESLIE L IVERSEN | 1 | 1 |
| MICHAEL T BORER | 1 | 1 |
| TORSTEN T RASMUSSEN | 1 | 1 |
| MARY ANN T GRAY | 1 | 1 |
| GLENN F BAITY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.